Inovatīvo tehnoloģiju izmantošanas pieredze diabēta ārstēšanā un kontrolē pacientiem ar 1.tipa cukura diabētu
No Thumbnail Available
Date
2021
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Rīgas Stradiņa universitāte
Rīga Stradiņš University
Rīga Stradiņš University
Abstract
Bakalaura darbs “Inovatīvo tehnoloģiju izmantošanas pieredze diabēta ārstēšanā un kontrolē pacientiem ar 1.tipa cukura diabētu”, autore Elīza Liparte. Tēma izvēlēta pamatojoties uz problēmas aktualitāti sabiedrībā un darba autores personīgo 13 gadu pieredzi sadzīvojot ar diagnozi 1.tipa cukura diabēts, kā arī pieredzi, kā jaunās, inovatīvās tehnoloģijas veiksmīgi atvieglo ikdienas dzīvi un ļauj efektīvāk kontrolēt slimību.
Pasaulē ar cukura diabētu slimo 34,2 miljoni cilvēku (NDSR, 2020). Šobrīd cukura diabēta pacientu skaits Latvijā nesasniedz pasaules vidējos rādītājus – Latvijā 4,5% (4561 uz 100 000) iedzīvotāju ir cukura diabēts, pasaulē pacientu skaits veido 8,5% (6138 uz 100 000) no kopējās populācijas (SPKC, 2017).
Latvijā pacientu skaits, kas slimo ar cukura diabētu strauji pieaug un tuvojas 100 000 cilvēku robežai. Pieaug arī izdevumi diabēta ārstēšanai un medikamentiem. Lai palielinātu diabēta ārstēšanas kvalitāti un sasniegtu labākus veselības rezultātus, būtu radikāli jāuzlabo diabēta pacientu apmācība un jāatceļ efektīvu terapiju lietošanas ierobežojumi (Gailiša, b.g.).
Inovatīvo tehnoloģiju pielietošana diabēta aprūpē paver iespējas padarīt diabēta aprūpi uz pacientu centrētāku, uzlabot aprūpi kopumā un mazināt pašreizējās un turpmākās diabēta komplikācijas (Prahalad, 2018).
Pētījuma mērķis: noskaidrot inovatīvo tehnoloģiju izmantošanas pieredzi diabēta ārstēšanā un kontrolē pacientiem ar 1.tipa cukura diabētu.
Pētījuma jautājums: kāda ir inovatīvo tehnoloģiju izmantošanas pieredze diabēta ārstēšanā un kontrolē pacientiem ar 1.tipa cukura diabētu?
Bakalaura darbs sastāv no divām daļām. Teorētiskajā daļā tiek apskatītas inovatīvās tehnoloģijas 1. tipa cukura diabētā ārstēšanā un kontrolē. Praktiskā pētījuma realizēšanā tika izmantota kvantitatīvā metode, veicot respondentu anketēšanu, kas notika attālināti izmantojot elektroniski sagatavotu aptaujas anketu. Pētījuma dalībnieki – pacienti ar 1.tipa cukura diabētu, kopumā 110. Pētījumam izvēlēts neeksperimentāls, salīdzinošs šķērsgriezuma dizains.
Pētījuma būtiskākie rezultāti ir - 62,7% respondentu ikdienā regulāri izmanto inovatīvās tehnoloģijas diabēta ārstēšanā un kontrolē, vīriešu grupā tie ir 51,7% un sieviešu 66,7%. Visbiežāk izmantotās ierīces cukura diabēta pacientu starpā ir glikozes monitorēšanas ierīces, kuras katru dienu izmanto 73,6% respondentu. Pēc finansiāla aspekta secinot aptaujas respondenti ik mēnesi atvēl no 101 līdz 150 euro nepieciešamo inovatīvo tehnoloģiju iegādei. Respondentu vidējais vērtējums par inovatīvo tehnoloģiju un ierīču lietošanu ir 4 - labi.
Atslēgvārdi: 1.tipa cukura diabēts, inovatīvās tehnoloģijas, glikozes monitorēšana, insulīna sūkņi, viedtālruņu aplikācijas.
Bachelor thesis "The experience of using innovative technologies in the treatment and control of diabetes in patients with 1st type diabetes", author Elīza Liparte. The topic was chosen on the basis of the urgency of the problem in society and the author's personal experience of 13 years of living with a diagnosis of type 1 diabetes, as well as her experience of how new, innovative technologies successfully facilitate everyday life and allow more effective control of the disease. Worldwide, 34.2 million people have diabetes (NDSR, 2020). Currently, the number of diabetes patients in Latvia is below the global average - 4.5% (4561 per 100 000) of the population in Latvia has diabetes, compared to 8.5% (6138 per 100 000) of the total population worldwide (SPKC, 2017). In Latvia, the number of people with diabetes is increasing rapidly and is approaching the 100 000 mark. Expenses on diabetes treatment and medicine are also rising. To increase the quality of diabetes treatment and achieve better health outcomes, training of diabetic patients should be radically improved and restrictions on the use of effective therapies should be withdraw (Gailiša, b.g.). The application of innovative technologies in diabetes care offers opportunities to make diabetes care more patient-centered, improve overall care and reduce current and future diabetes complications (Prahalad, 2018). Aim of the research: to investigate the experience of using innovative technologies in the treatment and control of diabetes in patients with type 1 diabetes. Research question: what is the experience of using innovative technologies in the treatment and control of diabetes in patients with type 1 diabetes? The theoretical part deals with innovative technologies in the treatment and control of type 1 diabetes. The practical part of the research was based on a quantitative method, using a questionnaire prepared electronically and administered remotely to the respondents. The participants were patients with type 1 diabetes, 110 in total. A non-experimental, comparative cross-sectional design was chosen for the study. The most important results of the study are that 62.7% of respondents regularly use innovative technologies for diabetes treatment and control on a daily basis, 51.7% in the male group and 66.7% of women. The most commonly used devices among diabetes patients are glucose monitoring devices, which are used daily by 73.6% of respondents. From a financial point of view, the survey respondents spend between 101 and 150 euro per month on the purchase of the necessary innovative technologies. The average rating of the respondents for the use of innovative technologies and devices is 4 or good. Keywords: type 1 diabetes, innovative technologies, glucose monitoring, insulin pumps, and smartphone apps.
Bachelor thesis "The experience of using innovative technologies in the treatment and control of diabetes in patients with 1st type diabetes", author Elīza Liparte. The topic was chosen on the basis of the urgency of the problem in society and the author's personal experience of 13 years of living with a diagnosis of type 1 diabetes, as well as her experience of how new, innovative technologies successfully facilitate everyday life and allow more effective control of the disease. Worldwide, 34.2 million people have diabetes (NDSR, 2020). Currently, the number of diabetes patients in Latvia is below the global average - 4.5% (4561 per 100 000) of the population in Latvia has diabetes, compared to 8.5% (6138 per 100 000) of the total population worldwide (SPKC, 2017). In Latvia, the number of people with diabetes is increasing rapidly and is approaching the 100 000 mark. Expenses on diabetes treatment and medicine are also rising. To increase the quality of diabetes treatment and achieve better health outcomes, training of diabetic patients should be radically improved and restrictions on the use of effective therapies should be withdraw (Gailiša, b.g.). The application of innovative technologies in diabetes care offers opportunities to make diabetes care more patient-centered, improve overall care and reduce current and future diabetes complications (Prahalad, 2018). Aim of the research: to investigate the experience of using innovative technologies in the treatment and control of diabetes in patients with type 1 diabetes. Research question: what is the experience of using innovative technologies in the treatment and control of diabetes in patients with type 1 diabetes? The theoretical part deals with innovative technologies in the treatment and control of type 1 diabetes. The practical part of the research was based on a quantitative method, using a questionnaire prepared electronically and administered remotely to the respondents. The participants were patients with type 1 diabetes, 110 in total. A non-experimental, comparative cross-sectional design was chosen for the study. The most important results of the study are that 62.7% of respondents regularly use innovative technologies for diabetes treatment and control on a daily basis, 51.7% in the male group and 66.7% of women. The most commonly used devices among diabetes patients are glucose monitoring devices, which are used daily by 73.6% of respondents. From a financial point of view, the survey respondents spend between 101 and 150 euro per month on the purchase of the necessary innovative technologies. The average rating of the respondents for the use of innovative technologies and devices is 4 or good. Keywords: type 1 diabetes, innovative technologies, glucose monitoring, insulin pumps, and smartphone apps.
Description
Māszinības (ar specializāciju Ambulatorās aprūpes māsa)
Nursing Studies
Veselības aprūpe
Health Care
Nursing Studies
Veselības aprūpe
Health Care
Keywords
1.tipa cukura diabēts, inovatīvās tehnoloģijas, glikozes monitorēšana, insulīna sūkņi, viedtālruņu aplikācijas., type 1 diabetes, innovative technologies, glucose monitoring, insulin pumps, and smartphone apps.